There are 2949 resources available
An overview of NSCLC
Presenter: Marina Garassino
Session: Janssen - Intrinsic and acquired resistance to EGFR TKIs: New therapies on the horizon
Resources:
Webcast
Uncommon EGFR mutations in NSCLC
Presenter: Zofia Piotrowska
Session: Janssen - Intrinsic and acquired resistance to EGFR TKIs: New therapies on the horizon
Resources:
Webcast
Live Q&A - 24 September 2020 - 17:00-17:30
Presenter: Eva Ciruelos
Session: F. Hoffmann-La Roche - Transforming patient care: Leveraging the latest clinical data in HER2-positive eBC
Resources:
Webcast
Live Q&A - 24 September 2020 - 17:30-18:00
Presenter: Arndt Vogel
Session: F. Hoffmann-La Roche - Integrating cancer immunotherapy combinations into HCC practice: Duos, data and decisions
Resources:
Webcast
Live Q&A - 24 September 2020 - 15:45-16:45
Presenter: Markus Möhler
Session: Bristol Myers Squibb - The future is now: Transforming management of GI cancer with immuno-oncology
Resources:
Webcast
Live Q&A - 24 September 2020 - 15:00-15:30
Presenter: George Demetri
Session: Pfizer Oncology - RWE and me: Multidisciplinary views on real-world evidence (RWE) in oncology
Resources:
Webcast
Live Q&A - 24 September 2020 - 15:30-16:00
Presenter: James Larkin
Session: Bristol Myers Squibb - Harnessing the Potential of the Immune System: Clinical Insights From Utilizing CTLA-4 Within a Dual I-O Approach in aRCC
Resources:
Webcast
Live Q&A - 18 September 2020 - 17:00-17:30
Presenter: Emile Voest
Session: F. Hoffmann-La Roche - Putting personalised healthcare at the heart of clinical practice
Resources:
Webcast
Live Q&A - 18 September 2020 - 16:15-16:45
Presenter: Antonio Llombart Cussac
Session: Pfizer Oncology - The complete picture: Managing breast cancer in the real-world
Resources:
Webcast
Live Q&A - 23 September 2020 - 10:00-10:30
Presenter: James Larkin
Session: Bristol Myers Squibb - Melanoma in 2020: Reflect, reset, and continue
Resources:
Webcast